Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Equity (2016 - 2025)

Historic Return on Equity for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to 0.18%.

  • United Therapeutics' Return on Equity changed 0.0% to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.19% for FY2024, which is 100.0% up from last year.
  • As of Q3 2025, United Therapeutics' Return on Equity stood at 0.18%, which was down 0.0% from 0.18% recorded in Q2 2025.
  • United Therapeutics' Return on Equity's 5-year high stood at 0.19% during Q2 2024, with a 5-year trough of 0.12% in Q1 2021.
  • Over the past 5 years, United Therapeutics' median Return on Equity value was 0.17% (recorded in 2023), while the average stood at 0.16%.
  • As far as peak fluctuations go, United Therapeutics' Return on Equity crashed by -700bps in 2021, and later surged by 500bps in 2022.
  • United Therapeutics' Return on Equity (Quarter) stood at 0.12% in 2021, then increased by 27bps to 0.16% in 2022, then rose by 8bps to 0.17% in 2023, then increased by 13bps to 0.19% in 2024, then decreased by -3bps to 0.18% in 2025.
  • Its Return on Equity was 0.18% in Q3 2025, compared to 0.18% in Q2 2025 and 0.18% in Q1 2025.